Business Description
Novelix Pharmaceuticals Ltd
ISIN : INE314I01036
Compare
Compare
Traded in other countries / regions
536565.India IPO Date
2009-03-25Description
Novelix Pharmaceuticals Ltd formerly Trimurthi Ltd is an India based pharmaceutical supplier. It operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, Foods, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.74 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.8 | |||||
| Beneish M-Score | -1.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -23 | |||||
| 3-Year EBITDA Growth Rate | 68.4 | |||||
| 3-Year Book Growth Rate | 2.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 100 | |||||
| 14-Day RSI | 100 | |||||
| 6-1 Month Momentum % | 21.44 | |||||
| 12-1 Month Momentum % | 111.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.71 | |||||
| Quick Ratio | 3.61 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 56.43 | |||||
| Days Sales Outstanding | 84.62 | |||||
| Days Payable | 73.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 10.25 | |||||
| Operating Margin % | -1.06 | |||||
| Net Margin % | 0.38 | |||||
| FCF Margin % | -5.82 | |||||
| ROE % | 0.29 | |||||
| ROA % | 0.25 | |||||
| ROIC % | -0.83 | |||||
| ROC (Joel Greenblatt) % | -11.21 | |||||
| ROCE % | -1.81 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 805 | |||||
| PE Ratio without NRI | 2415 | |||||
| PS Ratio | 3.3 | |||||
| PB Ratio | 2.68 | |||||
| Price-to-Tangible-Book | 2.67 | |||||
| EV-to-EBIT | -167.75 | |||||
| EV-to-EBITDA | -206.4 | |||||
| EV-to-Revenue | 4.01 | |||||
| EV-to-FCF | -68.86 | |||||
| Price-to-Projected-FCF | 8.39 | |||||
| Price-to-Median-PS-Value | 4.07 | |||||
| Price-to-Graham-Number | 16.89 | |||||
| Price-to-Net-Current-Asset-Value | 2.73 | |||||
| Earnings Yield (Greenblatt) % | -0.6 | |||||
| FCF Yield % | -1.43 | |||||
| Forward Rate of Return (Yacktman) % | -33.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novelix Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 58.994 | ||
| EPS (TTM) (₹) | 0.03 | ||
| Beta | 0.21 | ||
| Volatility % | 45.09 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR (₹) | 0.061112 | ||
| 20-Day SMA (₹) | 23.4025 | ||
| 12-1 Month Momentum % | 111.01 | ||
| 52-Week Range (₹) | 8.1 - 24.15 | ||
| Shares Outstanding (Mil) | 9.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Novelix Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Novelix Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Novelix Pharmaceuticals Ltd Frequently Asked Questions
What is Novelix Pharmaceuticals Ltd(BOM:536565)'s stock price today?
The current price of BOM:536565 is ₹24.15. The 52 week high of BOM:536565 is ₹24.15 and 52 week low is ₹8.10.
When is next earnings date of Novelix Pharmaceuticals Ltd(BOM:536565)?
The next earnings date of Novelix Pharmaceuticals Ltd(BOM:536565) is .
Does Novelix Pharmaceuticals Ltd(BOM:536565) pay dividends? If so, how much?
Novelix Pharmaceuticals Ltd(BOM:536565) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers